Protease-activated receptor 2 (PAR-2), a member of a family of GPCRs, is frequently overexpressed in various human cancers, and that PAR-2-induced cisplatin resistance is dependent on EGFR transactivation in cervical cancer [17]. This evidence concerns the gene F2RL1 and cancer.